Circulation-Cardiovascular Quality and Outcomes

Papers
(The median citation count of Circulation-Cardiovascular Quality and Outcomes is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Race, Racism, and Cardiovascular Health: Applying a Social Determinants of Health Framework to Racial/Ethnic Disparities in Cardiovascular Disease137
Recommendations for Reporting Machine Learning Analyses in Clinical Research120
Importance of Housing and Cardiovascular Health and Well-Being: A Scientific Statement From the American Heart Association75
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to 72
The Groundwater of Racial and Ethnic Disparities Research71
Rapid Diet Assessment Screening Tools for Cardiovascular Disease Risk Reduction Across Healthcare Settings: A Scientific Statement From the American Heart Association59
Randomized Pragmatic Trial of Stroke Transitional Care53
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients52
Understanding How Cardiac Arrest Complicates the Analysis of Clinical Trials of Cardiogenic Shock47
Changes in the United States Adult Heart Allocation Policy46
Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration46
Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014–201846
Cardiovascular and Cerebrovascular Disease Mortality in Asian American Subgroups44
Characteristics and Outcomes of In-Hospital Cardiac Arrest Events During the COVID-19 Pandemic43
American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines42
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure40
Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis39
Utilization and Availability of Advanced Imaging in Patients With Acute Ischemic Stroke39
Harnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart Association39
Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis38
Psychological Outcomes and Interventions for Individuals With Congenital Heart Disease: A Scientific Statement From the American Heart Association37
Contemporary Trends in Hospital Admissions and Outcomes in Patients With Critical Limb Ischemia36
External Validations of Cardiovascular Clinical Prediction Models: A Large-Scale Review of the Literature35
Digital Health Intervention in Acute Myocardial Infarction35
Working Agenda for Black Mothers33
Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease Among Medicare Beneficiaries Between 2017 and 2018: Participation Rates and Outcomes33
Use of Mobile Health Applications in Low-Income Populations33
Cardiovascular Health Score and Lifetime Risk of Cardiovascular Disease32
Million Hearts Cardiac Rehabilitation Think Tank: Accelerating New Care Models31
Cardio-Renal-Metabolic Care Models31
Comparative Efficacy of 5 Exercise Types on Cardiometabolic Health in Overweight and Obese Adults: A Systematic Review and Network Meta-Analysis of 81 Randomized Controlled Trials31
Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States28
Impact of COVID-19 Pandemic on Critical Care Transfers for ST-Segment–Elevation Myocardial Infarction, Stroke, and Aortic Emergencies28
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis28
Social Determinants of Health Improve Predictive Accuracy of Clinical Risk Models for Cardiovascular Hospitalization, Annual Cost, and Death28
Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases28
Preventing and Managing Falls in Adults With Cardiovascular Disease: A Scientific Statement From the American Heart Association27
Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–201827
Performance Metrics for the Comparative Analysis of Clinical Risk Prediction Models Employing Machine Learning26
ABCs of Stroke Prevention25
Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease24
Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Independent External Validations of 104 Unique Models24
Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation23
Microrandomized Trial Design for Evaluating Just-in-Time Adaptive Interventions Through Mobile Health Technologies for Cardiovascular Disease21
Variation in Out-of-Hospital Cardiac Arrest Survival Across Emergency Medical Service Agencies20
Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study20
Sudden Cardiac Death in the Young20
Disparities and Impact of Medicaid Expansion on Left Ventricular Assist Device Implantation and Outcomes20
2021 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-1920
Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial Fibrillation20
Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study20
Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy20
Socioeconomic Burden of Rising Methamphetamine-Associated Heart Failure Hospitalizations in California From 2008 to 201820
Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer20
Determinants of Hospital Variation in Cardiac Rehabilitation Enrollment During Coronary Artery Disease Episodes of Care19
Streamlining and Reimagining Prior Authorization Under Value-Based Contracts: A Call to Action From the Value in Healthcare Initiative’s Prior Authorization Learning Collaborative19
Relationship of Preeclampsia With Maternal Place of Birth and Duration of Residence Among Non-Hispanic Black Women in the United States19
Ten-Year Trends in Patient Characteristics, Treatments, and Outcomes in Myocardial Infarction From National Cardiovascular Data Registry Chest Pain–MI Registry19
Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease19
Transcatheter Aortic Valve Replacement in Low-Population Density Areas18
Characteristics and Quality of National Cardiac Registries: A Systematic Review18
Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States18
Rural-Urban Differences in Mortality From Ischemic Heart Disease, Heart Failure, and Stroke in the United States18
County-Level Social Vulnerability is Associated With In-Hospital Death and Major Adverse Cardiovascular Events in Patients Hospitalized With COVID-19: An Analysis of the American Heart Association COV18
Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System17
Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease17
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-1917
Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial17
Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial17
Text Message Medication Adherence Reminders Automated and Delivered at Scale Across Two Institutions: Testing the Nudge System: Pilot Study16
Higher Emergency Physician Chest Pain Hospitalization Rates Do Not Lead to Improved Patient Outcomes16
2022 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Car16
Impact of Produce Prescriptions on Diet, Food Security, and Cardiometabolic Health Outcomes: A Multisite Evaluation of 9 Produce Prescription Programs in the United States16
The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study16
Estimating the Effect of Reduced Attendance at Emergency Departments for Suspected Cardiac Conditions on Cardiac Mortality During the COVID-19 Pandemic16
Food Insecurity and Cardiovascular Mortality for Nonelderly Adults in the United States From 2011 to 201716
Cardiologist Evaluation of Patients With Type 2 Myocardial Infarction16
Integrated Care in Atrial Fibrillation15
Severe Maternal Morbidity and Long-Term Risk of Cardiovascular Hospitalization15
Cardiovascular Disease Risk–Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network15
Role of Frailty in Identifying Benefit From Transcatheter Versus Surgical Aortic Valve Replacement15
Navigating Healthcare Supply Shortages During the COVID-19 Pandemic15
Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction15
Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes14
Conflicting Perspectives on the Value of Neprilysin Inhibition in Heart Failure Revealed During Development of a Decision Aid Focusing on Patient Costs for Sacubitril/Valsartan14
ST-Segment–Elevation Myocardial Infarction Care and COVID-1914
Trends in Consumer Wearable Devices With Cardiac Sensors in a Primary Care Cohort14
Survival After In-Hospital Cardiac Arrest in Critically Ill Patients14
Show Me the Money14
Mendelian Randomization in Cardiovascular Research14
Practical Application of Patient-Reported Health Status Measures for Transcatheter Valve Therapies14
Cardiovascular Disease Events and Mortality After Myocardial Infarction Among Black and White Adults14
Trends in Arterial Access Site Selection and Bleeding Outcomes Following Coronary Procedures, 2011–201814
Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials13
Patient Perspectives on the Completion and Use of Patient-Reported Outcome Surveys in Routine Clinical Care for Heart Failure13
Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Dis13
Hybrid Training in Acute Cardiovascular Care13
Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction13
Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 201813
Cardiac Rehabilitation and the COVID-19 Pandemic: Persistent Declines in Cardiac Rehabilitation Participation and Access Among US Medicare Beneficiaries13
Socioeconomic Status and Outcomes in Heart Failure With Reduced Ejection Fraction From Asia13
Sources of Hospital Variation in Postacute Care Spending After Cardiac Surgery13
Individual Psychosocial Resilience, Neighborhood Context, and Cardiovascular Health in Black Adults13
Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models12
2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Associati12
2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Dat12
Palliative Care Across the Life Span for Children With Heart Disease: A Scientific Statement From the American Heart Association12
Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome12
National Trends of Sex Disparity in the American College of Cardiology/American Heart Association Guideline Writing Committee Authors Over 15 Years12
Provider Care Team Segregation and Operative Mortality Following Coronary Artery Bypass Grafting11
Effectiveness of Stroke Early Supported Discharge11
Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration11
Relationship Between Social Determinants of Health and Antihypertensive Medication Adherence in a Medicaid Cohort11
Role of Spirituality on the Association Between Depression and Quality of Life in Stroke Survivor–Care Partner Dyads11
Longer-Term Results of a Universal Electronic Consultation Program at the Cardiology Department of a Galician Healthcare Area11
Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry11
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER11
Association Between Early Trauma and Ideal Cardiovascular Health Among Black Americans11
Benefits and Harms of Hypertension and High-Normal Labels: A Randomized Experiment11
Cause of Death Among Patients With Peripheral Artery Disease11
Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke11
Associations of Medicaid Expansion With Access to Care, Severity, and Outcomes for Acute Ischemic Stroke11
Best Practices for Education and Training of Resuscitation Teams for In-Hospital Cardiac Arrest10
Long-Term Prognosis of Patients With Coexisting Obesity and Malnutrition After Acute Myocardial Infarction: A Cohort Study10
Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States10
Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction10
In-Hospital Cardiac Arrest Survival in the United States During and After the Initial Novel Coronavirus Disease 2019 Pandemic Surge10
Toward Dynamic Risk Prediction of Outcomes After Coronary Artery Bypass Graft: Improving Risk Prediction With Intraoperative Events Using Gradient Boosting10
Why Fibrinolytic Therapy for ST-Segment–Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend10
Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial10
Risk Stratification of Patients Undergoing Percutaneous Repair of Mitral and Tricuspid Valves Using a Multidimensional Geriatric Assessment10
Joint Modeling of Longitudinal Markers and Time-to-Event Outcomes: An Application and Tutorial in Patients After Surgical Repair of Transposition of the Great Arteries10
Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical Trial9
Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries9
Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended In9
Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events9
Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY9
Contributions of Structural Racism to the Food Environment: A Photovoice Study of Black Residents With Hypertension in Baltimore, MD9
Social Determinants of Adherence to COVID-19 Risk Mitigation Measures Among Adults With Cardiovascular Disease9
Validity of International Classification of Diseases (ICD)-10 Diagnosis Codes for Identification of Acute Heart Failure Hospitalization and Heart Failure with Reduced Versus Preserved Ejection Fractio9
Reimagining Evidence Generation for Heart Failure and the Role of Integrated Health Care Systems9
Screening for Intracranial Aneurysms in Coarctation of the Aorta9
Hospital and Operator Variation in Cardiac Rehabilitation Referral and Participation After Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortiu9
Trends of Coronary Artery Bypass Grafting Performance in a Cohort of Hospitals in China Between 2013 and 20189
Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association9
Adverse Pregnancy Conditions Among Privately Insured Women With and Without Congenital Heart Defects9
The New Adult Heart Allocation Policy8
Trajectories of Pain After Cardiac Surgery: Implications for Measurement, Reporting, and Individualized Treatment8
Rationale and Design of the SAFE-PAD Study8
Exposure to Neighborhood-Level Racial Residential Segregation in Young Adulthood to Midlife and Incident Subclinical Atherosclerosis in Black Adults: The Coronary Artery Risk Development in Young Adul8
Use of Artificial Intelligence Tools Across Different Clinical Settings8
Practice Patterns and Outcomes Associated With Anticoagulation Use Following Sepsis Hospitalizations With New-Onset Atrial Fibrillation8
Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis8
Perioperative Considerations for Pediatric Patients With Congenital Heart Disease Presenting for Noncardiac Procedures: A Scientific Statement From the American Heart Association8
Examination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance System8
Interim Guidance for Emergency Medical Services Management of Out-of-Hospital Cardiac Arrest During the COVID-19 Pandemic7
Systemizing the Evaluation of Acute Heart Failure in the Emergency Department7
Competitive Sports, the Coronavirus Disease 2019 Pandemic, and Big Ten Athletics7
Changes in Home Blood Pressure Monitored Among Elderly Patients With Hypertension During the COVID-19 Outbreak: A Longitudinal Study in China Leveraging a Smartphone-Based Application7
Association of State Medicaid Expansion Status With Hypertensive Disorders of Pregnancy in a Singleton First Live Birth7
Variation in Cardiac Rehabilitation Participation During Aortic Valve Replacement Episodes of Care7
Examining Neighborhood Socioeconomic Status as a Mediator of Racial/Ethnic Disparities in Hypertension Control Across Two San Francisco Health Systems7
Cardiovascular Risk Assessment Using Artificial Intelligence-Enabled Event Adjudication and Hematologic Predictors7
The Cardiovascular Quality Improvement and Care Innovation Consortium7
Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework?7
Progression of Preclinical Heart Failure: A Description of Stage A and B Heart Failure in a Community Population7
Personalized, Electronic Health Record–Integrated Decision Aid for Stroke Prevention in Atrial Fibrillation: A Small Cluster Randomized Trial and Qualitative Analysis of Efficacy and Acceptability7
Relation of Household Income to Access and Adherence to Combination Sacubitril/Valsartan in Heart Failure: A Retrospective Analysis of Commercially Insured Patients7
Efforts to Improve Survival Outcomes of Out-of-Hospital Cardiac Arrest in China: BASIC-OHCA7
Reflections on the Values of Community-Based Participatory Research in Supporting Mobile Health Technology Use7
Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study7
Coronary Artery Bypass Surgery in Patients With COVID-197
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 20197
Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation7
Quantifying Blood Pressure Visit-to-Visit Variability in the Real-World Setting: A Retrospective Cohort Study7
Generalizability of DAPA-CKD to the United States7
Frontiers of Upstream Stroke Prevention and Reduced Stroke Inequity Through Predicting, Preventing, and Managing Hypertension and Atrial Fibrillation7
Financial Toxicity With Cardiovascular Disease Management6
Early Stage and Established Hypertension in Sub-Saharan Africa: Results From Population Health Surveys in 17 Countries, 2010–20176
Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients6
Ten Steps Toward Improving In-Hospital Cardiac Arrest Quality of Care and Outcomes6
Improving Outcome Predictions for Patients Receiving Mechanical Circulatory Support by Optimizing Imputation of Missing Values6
American Heart Association Precision Medicine Platform Addresses Challenges in Data Sharing6
Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations6
Addressing Gaps in Racial/Ethnic Representation in Familial Hypercholesterolemia Registries6
Cardiometabolic Risk Factor Control During Times of Crises and Beyond6
Social Determinants of Cardiovascular Health in an Era of Rising Social Disadvantage6
Sociodemographic Disparities in Outpatient Cardiology Telemedicine During the COVID-19 Pandemic6
Impact of Medicare’s Bundled Payments Initiative on Patient Selection, Payments, and Outcomes for Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting6
One-Year Outcomes and Factors Associated With Mortality Following Acute Myocardial Infarction in Northern Tanzania6
Integrating Community Health Workers into Community-Based Primary Care Practice Settings to Improve Blood Pressure Control Among South Asian Immigrants in New York City: Results from a Randomized Cont6
Comparison of 0/3-Hour Rapid Rule-Out Strategies Using High-Sensitivity Cardiac Troponin I in a US Emergency Department6
Contemporary Rates of Hospitalization for Heart Failure in Young and Middle-Aged Adults in a Diverse US State6
Rates and Predictors of Patient Underreporting of Hospitalizations During Follow-Up After Acute Myocardial Infarction6
Safer Stroke-Dx Instrument: Identifying Stroke Misdiagnosis in the Emergency Department6
Incidence of Timely Outpatient Follow-Up Care After Emergency Department Encounters for Acute Heart Failure6
Statin Prescribing Patterns During In-Person and Telemedicine Visits Before and During the COVID-19 Pandemic6
Increasing Uptake of Depression Screening and Treatment Guidelines in Cardiac Patients: A Behavioral and Implementation Science Approach to Developing a Theory-Informed, Multilevel Implementation Stra6
Establishing Thresholds for Minimal Clinically Important Differences for the Peripheral Artery Disease Questionnaire6
Association of Cardiac Care Regionalization With Access, Treatment, and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction6
Determinants of Value in Coronary Artery Bypass Grafting5
Influence of Hospital Characteristics on Hospital Transfer Destinations for Patients With Stroke5
2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force 5
Early Termination of Acute Stroke Randomized Controlled Trials Published Between 2013 and 2020: A Systematic Review5
Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of5
Patients With Acute Coronary Syndromes Admitted to Contemporary Cardiac Intensive Care Units: Insights From the CCCTN Registry5
Cost Effectiveness of Interhospital Transfer for Mechanical Thrombectomy of Acute Large Vessel Occlusion Stroke5
Inflection Point5
Echocardiographic and Electrocardiographic Abnormalities Among Elderly Adults With Cardiovascular Disease in Rural South Africa5
Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial5
Traditional Chinese Medicine in Treating Hypertension5
Validation of the International Classification of Diseases, Tenth Revision Code for the National Institutes of Health Stroke Scale Score5
Accuracy of Cardiovascular Trial Outcome Ascertainment and Treatment Effect Estimates from Routine Health Data: A Systematic Review and Meta-Analysis5
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers5
Estimating Long-Term Health Utility Scores and Expenditures for Cardiovascular Disease From the Medical Expenditure Panel Survey5
Changes in Emergency Department Arrival Times for Acute Myocardial Infarction During the COVID-19 Pandemic Suggest Delays in Care Seeking5
Optimal Methods for Reducing Proxy-Introduced Bias on Patient-Reported Outcome Measurements for Group-Level Analyses5
Approval, Evidence, and “Off-Label” Device Utilization: The Patent Foramen Ovale Closure Story5
Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials5
The Accreditation Council for Graduate Medical Education Mandates That You Attempt to Enhance Diversity in Your Cardiology Program5
Electronic Health Record Integration of Predictive Analytics to Select High-Risk Stable Patients With Non–ST-Segment–Elevation Myocardial Infarction for Intensive Care Unit Admission5
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative5
Leveraging Remote Physiologic Monitoring in the COVID-19 Pandemic to Improve Care After Cardiovascular Hospitalizations5
Response by Chan to Letter Regarding Article, “In-Hospital Cardiac Arrest Survival in the United States During and After the Initial Novel Coronavirus Disease 2019 Pandemic Surge”5
Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department5
Artificial Intelligence–Enabled Model for Early Detection of Left Ventricular Hypertrophy and Mortality Prediction in Young to Middle-Aged Adults5
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation5
Why Is Intravascular Ultrasound Guidance Underutilized in Percutaneous Coronary Intervention?: It Is Not “All About the Benjamins”5
Understanding Baseline Physical Activity in Cardiac Rehabilitation Enrollees Using Mobile Health Technologies5
Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial5
Does Dog Ownership Really Prolong Survival?5
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization5
Evidence-Based Process Performance Measures and Clinical Outcomes in Patients With Incident Heart Failure With Reduced Ejection Fraction: A Danish Nationwide Cohort Study5
Catheterization Laboratory Activation Time in Patients Transferred With ST-Segment–Elevation Myocardial Infarction: Insights From the Mission: Lifeline STEMI Accelerator-2 Project5
Innovative Managed Care May Be Related to Improved Prognosis for Acute Myocardial Infarction Survivors5
Cardiovascular Patient Perspectives on Value in the Healthcare Experience5
Association Between Increased Hospital Reimbursement for Cardiac Rehabilitation and Utilization of Cardiac Rehabilitation by Medicare Beneficiaries4
Urban Spatial Accessibility of Primary Care and Hypertension Control and Awareness on Chicago’s South Side: A Study From the COMPASS Cohort4
Adherence to Pediatric Universal Cholesterol Testing Guidelines Across Body Mass Index Categories: A CER 2 Cohort Study4
Status of Maternal Cardiovascular Health in American Indian and Alaska Native Individuals: A Scientific Statement From the American Heart Association4
Machine Learning in Clinical Journals4
Comparative Effectiveness Research and Cardiovascular Device Registries: Aligning Policy and Methods4
Thirty-Day and 90-Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries4
Relationship Between Social Vulnerability Indicators and Trial Participant Attrition: Findings From the HYVALUE Trial4
Unblinded and Blinded N-of-1 Trials Versus Usual Care: A Randomized Controlled Trial to Increase Statin Uptake in Primary Care4
Patient Preferences for Pharmaceutical and Device-Based Treatments for Uncontrolled Hypertension: Discrete Choice Experiment4
Nationwide Implementation of a Population Management Dashboard for Monitoring Direct Oral Anticoagulants: Insights From the Veterans Affairs Health System4
Identifying and Addressing Gaps in the Care of Patients With Severe Valve Disease4
Long-Term Outcomes for Out-of-Hospital Cardiac Arrest in Elderly Patients: An Analysis of Cardiac Arrest Registry to Enhance Survival Data Linked to Medicare Files4
Development of the Elective Outpatient Percutaneous Coronary Intervention Episode–Based Cost Measure4
0.068876028060913